Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis

[1] Avina-Zubieta JA(2013)Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study Rheumatol (Oxford) 52 68-75

[2] Abrahamowicz M(2003)Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 1303-1307

[3] De Vera MA(2001)High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2737-2745

[4] Choi HK(2010)EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 325-331

[5] Sayre EC(2010)Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity Ann Rheum Dis 69 1920-1925

[6] Rahman MM(2012)Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy Rheumatol (Oxford) 51 451-459

[7] Solomon DH(2002)Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 1173-1177

[8] Karlson EW(2014)Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis Arthritis Care Res (Hoboken) 66 355-363

[9] Rimm EB(2007)Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 56 2905-12

[10] Cannuscio CC(1991)Evidence for peripheral impaired glucose handling in patients with connective tissue diseases Metabolism 40 902-907

[1] Avina-Zubieta JA(2013)Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study Rheumatol (Oxford) 52 68-75

[2] Abrahamowicz M(2003)Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 1303-1307

[3] De Vera MA(2001)High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2737-2745

[4] Choi HK(2010)EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 325-331

[5] Sayre EC(2010)Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity Ann Rheum Dis 69 1920-1925

[6] Rahman MM(2012)Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy Rheumatol (Oxford) 51 451-459

[7] Solomon DH(2002)Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 1173-1177

[8] Karlson EW(2014)Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis Arthritis Care Res (Hoboken) 66 355-363

[9] Rimm EB(2007)Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 56 2905-12

[10] Cannuscio CC(1991)Evidence for peripheral impaired glucose handling in patients with connective tissue diseases Metabolism 40 902-907